Abstract
Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Current Alzheimer Research
Title: Risk Factors of Alzheimers Disease Among Iranian Population
Volume: 5 Issue: 1
Author(s): Mahshid Foroughan, Zia Ghaemmagham Farahani, Maryam Shariatpanahi, Mehrak Vaezinejad, Ahmad Ali Akbari Kamerani and Mehrdad Sheikhvatan
Affiliation:
Keywords: Alzheimer's disease, Risk factors, Hypertension, Smoking, Diabetes mellitus
Abstract: Background: Several demographic, environmental and clinical risk factors have been determined as possible risk/protective factors of Alzheimers disease (AD). The purpose of this study was to find out which one of these known factors is related to developing of AD in Iranian population. Materials and Methods: In a case-control study, 115 elderly patients (mean age of 70±8.18 years) with DSM-IV based final diagnosis compared with 115 non-demented counterparts matched for age ,sex, and socioeconomic status regarding lifestyle, family history, and history of bio-psychosocial health. Results: All differences between the two groups were non-significant except for history of hypertension (P=0.018) which was most prevalent in AD group. Risk of the incident AD for the hypertensive group was 1.71 (1.08-2.70) compared to the non-hypertensive group. Conclusion: These results confirm the previously reported relationship between AD and vascular factors. Prevention, early detection, and treatment of hypertension may have some implications in the primary and secondary prevention of AD.
Export Options
About this article
Cite this article as:
Foroughan Mahshid, Farahani Ghaemmagham Zia, Shariatpanahi Maryam, Vaezinejad Mehrak, Akbari Kamerani Ali Ahmad and Sheikhvatan Mehrdad, Risk Factors of Alzheimers Disease Among Iranian Population, Current Alzheimer Research 2008; 5 (1) . https://dx.doi.org/10.2174/156720508783884594
DOI https://dx.doi.org/10.2174/156720508783884594 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Characterization of Rhodamine Conjugated Agiotensin II Peptide: Synthesis, Analysis and Receptor Binding and Internalization.
Protein & Peptide Letters Renal Solute Transporters and Their Relevance to Serum Urate Disorder
Current Hypertension Reviews Investigating Drug Repositioning Approach to Design Novel Prodrugs for Colon-specific Release of Fexofenadine for Ulcerative Colitis
Current Drug Delivery Impact of Metabolic Surgery on Type-2 Diabetes Remission
Current Diabetes Reviews Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke
Current Neuropharmacology The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Mevalonate-Ras Homology (Rho)/Rho-Associated Coiled-Coil-Forming Protein Kinase (ROCK)-Mediated Signaling Pathway as a Therapeutic Target for the Treatment of Endometriosis-Associated Fibrosis
Current Signal Transduction Therapy Oxidative Stress and Vascular Disease
Current Hypertension Reviews Patent Selections
Recent Patents on Cardiovascular Drug Discovery D3 Dopamine Receptor and Essential Hypertension
Current Hypertension Reviews Risk Factors for Development of Heart Failure
Current Cardiology Reviews Membrane Bound Members of the M1 Family: More Than Aminopeptidases
Protein & Peptide Letters Recent Advances in Targeted Therapy for Glioma
Current Medicinal Chemistry Hypertension: Quo Vadis?
Current Vascular Pharmacology Common Variant in VEGFA and Response to Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration
Current Molecular Medicine Immunomodulatory Role of Arsenic in Regulatory T Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Novel Role of NPC1L1 in the Regulation of Hepatic Metabolism: Potential Contribution of Ezetimibe in NAFLD/NASH Treatment
Current Vascular Pharmacology Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Potential Cell Signalling Mechanisms Involved in Differential Placental Angiogenesis in Mild and Severe Pre-Eclampsia
Current Vascular Pharmacology